Fig. 1
From: Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
Interaction analysis of USP21 with Ranmogenin A (green), Tokorogenin (magenta), and BAY-805 (cyan). (A) Cartoon view of USP21 with the selected compounds, (B) Magnified cartoon view of USP21 with the selected compounds, (C) Surface representation of USP21 with the selected compounds.
